73 related articles for article (PubMed ID: 15035193)
1. [Geranylgeranylacetone, an antiulcer drug, potently inhibits formation and function of human osteoclasts in vitro and bone loss in ovariectomized rats].
Nanke Y; Kotake S; Kamatani N
Nihon Rinsho; 2004 Feb; 62 Suppl 2():575-9. PubMed ID: 15035193
[No Abstract] [Full Text] [Related]
2. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats.
Nanke Y; Kotake S; Ninomiya T; Furuya T; Ozawa H; Kamatani N
Calcif Tissue Int; 2005 Dec; 77(6):376-85. PubMed ID: 16362462
[TBL] [Abstract][Full Text] [Related]
3. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
4. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
[TBL] [Abstract][Full Text] [Related]
5. Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo.
Lee J; Noh AL; Zheng T; Kang JH; Yim M
Exp Cell Res; 2015 Dec; 339(2):380-8. PubMed ID: 26450448
[TBL] [Abstract][Full Text] [Related]
6. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway.
Li F; Sun X; Ma J; Ma X; Zhao B; Zhang Y; Tian P; Li Y; Han Z
Biochem Biophys Res Commun; 2014 Sep; 452(3):629-35. PubMed ID: 25181344
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of the leaves of loquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation.
Tan H; Furuta S; Nagata T; Ohnuki K; Akasaka T; Shirouchi B; Sato M; Kondo R; Shimizu K
J Agric Food Chem; 2014 Jan; 62(4):836-41. PubMed ID: 24404864
[TBL] [Abstract][Full Text] [Related]
8. 9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis.
Goel A; Raghuvanshi A; Kumar A; Gautam A; Srivastava K; Kureel J; Singh D
Mol Cell Endocrinol; 2015 Aug; 411():155-66. PubMed ID: 25957087
[TBL] [Abstract][Full Text] [Related]
9. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
10. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
11. Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis.
Kuo TH; Lin TH; Yang RS; Kuo SC; Fu WM; Hung HY
J Med Chem; 2015 Jun; 58(12):4954-63. PubMed ID: 25996239
[TBL] [Abstract][Full Text] [Related]
12. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function.
Li S; Liu B; Zhang L; Rong L
Bone; 2014 Apr; 61():164-75. PubMed ID: 24473375
[TBL] [Abstract][Full Text] [Related]
15. Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases.
Suzuki N; Somei M; Seki A; Reiter RJ; Hattori A
J Pineal Res; 2008 Oct; 45(3):229-34. PubMed ID: 18691356
[TBL] [Abstract][Full Text] [Related]
16. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
17. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
[TBL] [Abstract][Full Text] [Related]
18. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
[TBL] [Abstract][Full Text] [Related]
19. Policosanol prevents bone loss in ovariectomized rats.
Noa M; Más R; Mendoza S; Gámez R; Mendoza N; González J
Drugs Exp Clin Res; 2004; 30(3):117-23. PubMed ID: 15366788
[TBL] [Abstract][Full Text] [Related]
20. [Animal models for bone and joint disease. RANKL-injected bone loss model].
Yasuda H
Clin Calcium; 2011 Feb; 21(2):197-208. PubMed ID: 21289416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
